Related references
Note: Only part of the references are listed.In vivo structure/function and expression analysis of the CX3C chemokine fractalkine
Ki-Wook Kim et al.
BLOOD (2011)
Vascular Smooth Muscle Cell Proliferation in Restenosis
Steven O. Marx et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2011)
Fractalkine Is a Novel Human Adipochemokine Associated With Type 2 Diabetes
Rachana Shah et al.
DIABETES (2011)
Chemokine receptor CX3CR1 promotes dendritic cell development under steady-state conditions
Marcin Lyszkiewicz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiation
Li Meng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling
Gemma E. White et al.
CARDIOVASCULAR RESEARCH (2010)
Subtle conformational changes between CX3CR1 genetic variants as revealed by resonance energy transfer assays
Kevin Darbandi-Tehrani et al.
FASEB JOURNAL (2010)
The Fractalkine Receptor CX3CR1 Protects Against Liver Fibrosis by Controlling Differentiation and Survival of Infiltrating Hepatic Monocytes
Karlin Raja Karlmark et al.
HEPATOLOGY (2010)
CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung
Cyrille Mionnet et al.
NATURE MEDICINE (2010)
CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival
Limor Landsman et al.
BLOOD (2009)
Mechanisms and consequences of macrophage apoptosis in atherosclerosis
Tracie Seimon et al.
JOURNAL OF LIPID RESEARCH (2009)
Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6Chi and Ly6Clo monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice
Christophe Combadiere et al.
CIRCULATION (2008)
Site-directed mutagenesis of the chemokine receptor CXCR6 suggests a novel paradigm for interactions with the ligand CXCL16
Sarah J. Petit et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
High glucose conditions induce upregulation of fractalkine and monocyte chemotactic protein-1 in human smooth muscle cells
Elena Dragomir et al.
THROMBOSIS AND HAEMOSTASIS (2008)
Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes
Christian Hundhausen et al.
JOURNAL OF IMMUNOLOGY (2007)
Ly-6C(hi) monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata
Filip K. Swirski et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis
Murray C. H. Clarke et al.
NATURE MEDICINE (2006)
Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation
IF Charo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Proline 326 in the c terminus of murine CX3CR1 prevents G-protein and phosphatidylinositol 3-kinase-dependent stimulation of Akt and extracellular signal-regulated kinase in chinese hamster ovary cells
CN Davis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
The chemokine and chemokine receptor superfamilies and their molecular evolution
Albert Zlotnik et al.
GENOME BIOLOGY (2006)
Adverse associations between CX3CR1 polymorphisms and risk of cardiovascular or cerebrovascular disease
E Lavergne et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Enhanced adhesive capacities of the naturally occurring Ile249-Met280 variant of the chemokine receptor CX3CR1
M Daoudi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1)
AD Lucas et al.
CIRCULATION (2003)
The disintegrin-like metalloproteinase ADAM 10 is involved in coinstitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion
C Hundhausen et al.
BLOOD (2003)
Fractalkine (CX3CL1) stimulated by nuclear factor κB (NF-κB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway
B Chandrasekar et al.
BIOCHEMICAL JOURNAL (2003)
Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice
C Combadière et al.
CIRCULATION (2003)
Fractalkine is expressed by smooth muscle cells in response to IFN-γ and TNF-α and is modulated by metalloproteinase activity
A Ludwig et al.
JOURNAL OF IMMUNOLOGY (2002)
Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease
D Moatti et al.
BLOOD (2001)
The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo
AD Lucas et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo
M Matloubian et al.
NATURE IMMUNOLOGY (2000)
The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia
SA Boehme et al.
JOURNAL OF IMMUNOLOGY (2000)
NF-κB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1β, TNF-α, and LPS
GE Garcia et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2000)
Share Paper
